Australia markets closed

Synvista Therapeutics, Inc. (SYNI)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.00000.0000 (0.00%)
As of 03:28PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 35.21
52-week change 3-99.00%
S&P500 52-week change 322.43%
52-week high 30.0001
52-week low 30.0000
50-day moving average 30.0001
200-day moving average 30.0001

Share statistics

Avg vol (3-month) 3352
Avg vol (10-day) 3367
Shares outstanding 52.59M
Implied shares outstanding 6N/A
Float 8N/A
% held by insiders 1N/A
% held by institutions 1N/A
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 20.02:1
Last split date 325 July 2007

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2007
Most-recent quarter (mrq)30 Sept 2008

Profitability

Profit margin 0.00%
Operating margin (ttm)-379,312.06%

Management effectiveness

Return on assets (ttm)-50.59%
Return on equity (ttm)-102.91%

Income statement

Revenue (ttm)54.73k
Revenue per share (ttm)0.02
Quarterly revenue growth (yoy)-27.60%
Gross profit (ttm)N/A
EBITDA -11.01M
Net income avi to common (ttm)-19.8M
Diluted EPS (ttm)-7.6570
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)7.96M
Total cash per share (mrq)3.08
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)2.01
Book value per share (mrq)1.73

Cash flow statement

Operating cash flow (ttm)-9.32M
Levered free cash flow (ttm)-3.78M